Clinical trial NCT03206619: A Health Recommeder System to Tailor Message Preferences in a Smoking Cessation Programme
Official title: Study on Patient Acceptance and Engagement of Timely Tailored Motivational Messages Sent by a Health Recommender System and Delivered Via a Mobile App for Smoking Cessation
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Smoking Cessation
Health Behavior
Smoking, Tobacco
Smoking
Keywords: smoking
habit
preference
behavior
tailoring
cessation
engagement
digital
mobile app
recommender system
Lead sponsor: University of Seville
Sponsor class: OTHER
Collaborators: name: Hospitales Universitarios Virgen del Rocío
name: Salumedia Tecnologías
name: Aristotle University Of Thessaloniki
name: Northern Greece Neurofeedback Center
First posted: 2017-07-02
Enrollment: 120
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Adult smokers living in Seville (Spain)

Brief summary: Patients attending the smoking cessation programme at the Virgen del Rocío University Hospital under the SoLoMo clinical trial of the SmokeFreeBrain project and provided with the SoLoMo mobile app will be observed for one year. This mobile app which sends the patients tailored health motivational messages selected by a health recommender system, and based on their user profile retrieved from an electronic health record. Patients' messages feedback and interactions with the app will be analyzed and evaluated following an observational prospective methodology to see whether patients like the messages, and measure the patient engagement with the health recommender system.


Eligibility criteria: Inclusion Criteria:

* Patients must be taken from the the smoking cessation unit of the Virgen del Rocio University Hospital (Seville, Spain)
* Patients must be willing to start the treatment to quit smoking
* Patients must own an Android smartphone and be able to interact with it
* Patients must be willing to and install the "Libre de Humos" smoking cessation app recommended by the doctor in the SmokeFreeBrain study.
* Patients must sign an informed consent

Exclusion Criteria:

* Patients have known previous adverse effects on the pharmacological treatment included in the study (Bupropion \& Varenicline)

Primary outcomes:
measure: Objective quality of the health recommender system
timeFrame: Up to 18 months
measure: Subjective quality of the health recommender system
timeFrame: Up to 18 months
measure: Engagement at aggregated level - Mobile application rolling retention
timeFrame: Up to 18 months
measure: Engagement at aggregated level - Mobile application session length distribution
timeFrame: Up to 18 months
measure: Engagement at aggregated level - Mobile application usage frequency
timeFrame: Up to 18 months
measure: Engagement at aggregated level - Number of sessions per user
timeFrame: Up to 18 months
measure: Engagement at aggregated level - Return rate
timeFrame: Up to 18 months
measure: Engagement at individual level
timeFrame: Up to 18 months
Secondary outcomes:
Other outcomes:
Locations:
city: Seville
country: Spain
facility: Virgen del Rocío University Hospital
Study officials:
References:
citation: Hors-Fraile S, Schneider F, Fernandez-Luque L, Luna-Perejon F, Civit A, Spachos D, Bamidis P, de Vries H. Tailoring motivational health messages for smoking cessation using an mHealth recommender system integrated with an electronic health record: a study protocol. BMC Public Health. 2018 Jun 5;18(1):698. doi: 10.1186/s12889-018-5612-5.